IOVS 2027
Intraocular inflammatory diseases involve complex interactions between immune mechanisms, ocular tissues, infectious agents, and systemic conditions. Current research is advancing our understanding of inflammatory pathways, autoimmunity, infection-related inflammation, and mechanisms of tissue damage. The development of biologic agents and targeted immunomodulatory therapies has expanded therapeutic approaches for patients with uveitis, scleritis, and related inflammatory disorders. Emerging biomarkers, advanced imaging, and molecular diagnostics may support earlier diagnosis, disease monitoring, and individualized treatment strategies. This session will explore clinical advances, immunological mechanisms, diagnostic innovations, emerging biomarkers, and therapeutic developments in ocular inflammation.
- Noninfectious Uveitis
- Infectious Uveitis
- Biologic Therapies
- Ocular Autoimmunity
- Inflammatory Biomarkers
Related Sessions
Tags
Uveitis, Scleritis & Intraocular Inflammation Conferences
- Uveitis, Scleritis & Intraocular Inflammation Meetings
- Uveitis, Scleritis & Intraocular Inflammation Events
- Uveitis, Scleritis & Intraocular Inflammation Summit
- Uveitis, Scleritis & Intraocular Inflammation Symposium
- Uveitis, Scleritis & Intraocular Inflammation Workshops
- International Conference on Uveitis, Scleritis & Intraocular Inflammation
- Global Conference on Uveitis, Scleritis & Intraocular Inflammation
- Uveitis, Scleritis & Intraocular Inflammation Hybrid Event
- Uveitis, Scleritis & Intraocular Inflammation Webinar
- Upcoming Event on Uveitis, Scleritis & Intraocular Inflammation